Annexon (ANNX) Competitors $2.15 +0.10 (+4.88%) Closing price 04:00 PM EasternExtended Trading$2.18 +0.03 (+1.40%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANNX vs. CRON, NUVB, VERV, VALN, MLYS, ATAI, IOVA, UPB, ORIC, and PHARShould you be buying Annexon stock or one of its competitors? The main competitors of Annexon include Cronos Group (CRON), Nuvation Bio (NUVB), Verve Therapeutics (VERV), Valneva (VALN), Mineralys Therapeutics (MLYS), atai Life Sciences (ATAI), Iovance Biotherapeutics (IOVA), Upstream Bio (UPB), Oric Pharmaceuticals (ORIC), and Pharming Group (PHAR). These companies are all part of the "pharmaceutical products" industry. Annexon vs. Its Competitors Cronos Group Nuvation Bio Verve Therapeutics Valneva Mineralys Therapeutics atai Life Sciences Iovance Biotherapeutics Upstream Bio Oric Pharmaceuticals Pharming Group Annexon (NASDAQ:ANNX) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations. Do analysts recommend ANNX or CRON? Annexon currently has a consensus target price of $12.50, indicating a potential upside of 481.40%. Given Annexon's stronger consensus rating and higher possible upside, equities analysts clearly believe Annexon is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Annexon 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher earnings & valuation, ANNX or CRON? Cronos Group has higher revenue and earnings than Annexon. Annexon is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnnexonN/AN/A-$138.20M-$1.29-1.67Cronos Group$117.61M8.14$41.08M$0.0550.00 Does the media refer more to ANNX or CRON? In the previous week, Cronos Group had 1 more articles in the media than Annexon. MarketBeat recorded 2 mentions for Cronos Group and 1 mentions for Annexon. Annexon's average media sentiment score of 0.88 beat Cronos Group's score of 0.45 indicating that Annexon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Annexon 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cronos Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in ANNX or CRON? 8.7% of Cronos Group shares are owned by institutional investors. 11.9% of Annexon shares are owned by company insiders. Comparatively, 7.3% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more volatility & risk, ANNX or CRON? Annexon has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Is ANNX or CRON more profitable? Cronos Group has a net margin of 14.19% compared to Annexon's net margin of 0.00%. Cronos Group's return on equity of -3.78% beat Annexon's return on equity.Company Net Margins Return on Equity Return on Assets AnnexonN/A -70.04% -57.67% Cronos Group 14.19%-3.78%-3.62% SummaryCronos Group beats Annexon on 9 of the 15 factors compared between the two stocks. Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANNX vs. The Competition Export to ExcelMetricAnnexonMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$225.27M$3.13B$5.75B$9.85BDividend YieldN/A2.28%6.67%4.51%P/E Ratio-1.6720.8978.4326.42Price / SalesN/A458.96546.94119.09Price / CashN/A44.5237.0558.92Price / Book0.789.9310.916.06Net Income-$138.20M-$53.38M$3.29B$266.28M7 Day Performance1.42%0.05%0.01%-0.76%1 Month Performance-15.02%7.08%7.06%3.83%1 Year Performance-61.54%11.92%50.09%24.39% Annexon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANNXAnnexon2.271 of 5 stars$2.15+4.9%$12.50+481.4%-62.1%$225.27MN/A-1.6760CRONCronos Group1.656 of 5 stars$2.60-0.2%N/A+12.9%$995.90M$117.61M51.90450NUVBNuvation Bio2.525 of 5 stars$2.88-0.7%$7.33+154.6%+5.9%$992.59M$7.87M-4.5760News CoverageVERVVerve Therapeutics2.1701 of 5 stars$11.13flat$14.57+30.9%N/A$992.13M$32.33M-5.27110VALNValneva2.1983 of 5 stars$9.43-19.0%$16.00+69.7%+20.8%$990.49M$183.52M-9.62700Short Interest ↑High Trading VolumeMLYSMineralys Therapeutics1.8405 of 5 stars$14.74-1.0%$32.25+118.8%+144.8%$986.80MN/A-4.1428News CoverageAnalyst ForecastATAIatai Life Sciences3.5121 of 5 stars$4.74+3.7%$11.25+137.3%+270.5%$979.53M$310K-6.8780High Trading VolumeIOVAIovance Biotherapeutics4.4883 of 5 stars$2.53-5.9%$11.90+370.4%-79.6%$973.39M$164.07M-2.06500Positive NewsUPBUpstream Bio2.5225 of 5 stars$16.73-5.1%$56.50+237.7%N/A$950.42M$2.37M0.0038News CoveragePositive NewsORICOric Pharmaceuticals4.7095 of 5 stars$9.62-1.2%$17.63+83.2%+5.3%$945.98MN/A-5.0980News CoveragePositive NewsAnalyst ForecastPHARPharming Group2.9372 of 5 stars$14.28+4.2%$30.00+110.1%+87.5%$938.65M$297.20M-109.85280News CoveragePositive NewsShort Interest ↓Gap Up Related Companies and Tools Related Companies CRON Competitors NUVB Competitors VERV Competitors VALN Competitors MLYS Competitors ATAI Competitors IOVA Competitors UPB Competitors ORIC Competitors PHAR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANNX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredNewegg (NEGG) Earns BULLISH Rating – Up 934%The last time he shared a free AI stock pick like this, it soared 100%.Chaikin Analytics | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annexon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANNX Stock Alerts